Ghofrani, H. A., & Grünig, E. (2016). Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: Data from the PATENT-2 open-label, randomised, long-term extension trial. The lancet. Respiratory medicine, 4(5), . https://doi.org/10.1016/S2213-2600(16)30019-4
Chicago-Zitierstil (17. Ausg.)Ghofrani, Hossein Ardeschir, und Ekkehard Grünig. "Predictors of Long-term Outcomes in Patients Treated with Riociguat for Pulmonary Arterial Hypertension: Data from the PATENT-2 Open-label, Randomised, Long-term Extension Trial." The Lancet. Respiratory Medicine 4, no. 5 (2016). https://doi.org/10.1016/S2213-2600(16)30019-4.
MLA-Zitierstil (9. Ausg.)Ghofrani, Hossein Ardeschir, und Ekkehard Grünig. "Predictors of Long-term Outcomes in Patients Treated with Riociguat for Pulmonary Arterial Hypertension: Data from the PATENT-2 Open-label, Randomised, Long-term Extension Trial." The Lancet. Respiratory Medicine, vol. 4, no. 5, 2016, https://doi.org/10.1016/S2213-2600(16)30019-4.